RenaissanceRe Expands Cat Bond Business With $340M Medici UCITS Fund

Zacks
03-06

RenaissanceRe Holdings Ltd. RNR recently introduced a new property catastrophe bond fund called RenaissanceRe Medici UCITS Fund, which is registered in Ireland. This fund is designed to give European and global investors access to RenaissanceRe’s catastrophe bond investment strategy within a European-regulated UCITS structure. The Central Bank of Ireland is regulating Medici UCITS.

The new fund is an extension of the company’s existing RenaissanceReMedici Fund Ltd., following similar investment principles. At 2024-end, RNR had 15.8% noncontrollingeconomic ownership in the Medici entity.

The fund started with $340 million in capital, including $140 million co-invested by RNR. While the fund is not expected to be consolidated into its financial statements, it will generate fee income, and RNR’s investment in it will be recorded at fair value.

This move aligns with RenaissanceRe’s broader strategy of expanding globally, diversifying capital sources and strengthening its investment platform. With the new fund, the company is aiming to connect with more European and global investors. This allows the company to attract more third-party capital, diversifying its investor base beyond traditional markets.

RNR’s Capital Partners team will serve as the investment manager for the fund. They highlighted 25-year success in managing third-party capital and building strong investor relationships. The move is expected to strengthen its catastrophe bonds business, helping them match capital with risk efficiently while also creating a stable revenue stream. By leveraging its risk expertise and deep experience in alternative capital management, RNR is well-positioned to generate consistent returns.

RNR’s Price Performance

Shares of RenaissanceRe have gained 7% in the past year compared with a 15.7% rise of the industry it belongs to.


Image Source: Zacks Investment Research

Zacks Rank & Key Picks

RenaissanceRe currently has a Zacks Rank #3 (Hold).

Some better-ranked players in the broader Finance space are ProAssurance Corporation PRA, HCI Group, Inc. HCI and Palomar Holdings, Inc. PLMR, each presently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The consensus mark for ProAssurance’s bottom line for 2025 is pegged at 91 cents per share. The stock has witnessed two upward estimate revisions in the past 30 days with no movement in the opposite direction. PRA beat earnings estimates in each of the last four quarters, with an average surprise of 152.7%.

The Zacks Consensus Estimate for HCI Group’s 2025 earnings per share indicates 102.2% year-over-year growth to $14.98. It beat earnings estimates in each of the last four quarters, with an average surprise of 45.7%. The consensus mark for HCI’s current-year revenues signals a 17.5% increase from a year ago.

The Zacks Consensus Estimate for Palomar Holdings’ 2025 earnings per share projects 31.8% year-over-year growth to $6.71. It beat earnings estimates in each of the last four quarters, with an average surprise of 16.6%. The consensus mark for PLMR’s current-year revenues signals 38.9% growth from a year ago.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

RenaissanceRe Holdings Ltd. (RNR) : Free Stock Analysis Report

ProAssurance Corporation (PRA) : Free Stock Analysis Report

HCI Group, Inc. (HCI) : Free Stock Analysis Report

Palomar Holdings, Inc. (PLMR) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10